FluroTech Ltd. (TEST.V)

0.2550 0.0000 (0.00%) As of 1:15PM EDT. Market open.

FluroTech Ltd.

Alastair Ross Technology Centre
637, 3553 - 31 Street N.W
Calgary, AB T2L 1Y1
Canada
833 949 8378
http://www.flurotech.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Danny D. Dalla-Longa C.A., CPA, CPA	Co-Founder, Pres, CEO & Director	160k	N/A	1954
Mr. Curtis Smith C.A., CPA	Chief Financial Officer	145k	N/A	N/A
Mr. Rex Hartley Kary	Consultant	160k	N/A	1957
Mr. Derek Clark	Exec. Commercialization Consultant	N/A	N/A	N/A

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the pandemic defense sector. It provides a pandemic defense platform, a saliva-based antigen test that targets active infections evidenced by the presence of live viral particles. The company is headquartered in Calgary, Canada.

Corporate Governance

FluroTech Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.